Edwards Lifesciences Corporation
Bioprosthetic tissue having a reduced propensity for in vivo calcification
Last updated:
Abstract:
A bioprosthetic tissue having a reduced propensity to calcify in vivo, the bioprosthetic tissue. The bioprosthetic tissue comprises an aldehyde cross-linked and stressed bioprosthetic tissue comprising exposed calcium, phosphate or immunogenic binding sites that have been reacted with a calcification mitigant. The bioprosthetic tissue has a reduced propensity to calcify in vivo as compared to aldehyde cross-linked bioprosthetic tissue that has not been stressed and reacted with the calcification mitigant.
Status:
Grant
Type:
Utility
Filling date:
7 Oct 2019
Issue date:
19 Apr 2022